mhurhangee/patent-ind-claim-en huggingface dataset:
A hydrogen occlusion body comprising: a hydrogen occlusion layer containing a material whose optical property reversibly changes upon hydrogenation and dehydrogenation; and a catalyst layer containing a palladium-ruthenium alloy, wherein the palladium-ruthenium alloy is represented by a general formula Pd 1-x Ru x with 0.15 < x < 0.55. a hydrogen occlusion layer containing a material whose optical property reversibly changes upon hydrogenation and dehydrogenation; and a catalyst layer containing a palladium-ruthenium alloy, wherein the palladium-ruthenium alloy is represented by a general formula Pd 1-x Ru x with 0.15 < x < 0.55.
A medical apparatus comprising: a treatment device including an accessing unit formed of either a puncture needle stickable into a patient or a catheter insertable into a blood vessel of the patient; an integrated detecting device provided as a unit, which includes: an electrocardiogram-measuring device configured to closely attach to a skin of the patient and being capable of measuring an electrocardiogram of the patient; and a blood-leakage-detecting device configured to attach to a position near the accessing unit and being capable of detecting blood of the patient that may leak from the accessing unit, wherein the integrated detecting device has a close-contact surface that is configured to be brought into close contact with the skin of the patient and a non-close-contact surface that is out of close contact with the skin of the patient, the close-contact surface being provided with the electrocardiogram-measuring device and an electrode that is electrically connectable to the electrocardiogram-measuring device and the non-close-contact surface being provided with the blood-leakage-detecting device and an electrode that is electrically connectable to the blood-leakage-detecting device . a treatment device including an accessing unit formed of either a puncture needle stickable into a patient or a catheter insertable into a blood vessel of the patient; an integrated detecting device provided as a unit, which includes: an electrocardiogram-measuring device configured to closely attach to a skin of the patient and being capable of measuring an electrocardiogram of the patient; and a blood-leakage-detecting device configured to attach to a position near the accessing unit and being capable of detecting blood of the patient that may leak from the accessing unit, wherein the integrated detecting device has a close-contact surface that is configured to be brought into close contact with the skin of the patient and a non-close-contact surface that is out of close contact with the skin of the patient, the close-contact surface being provided with the electrocardiogram-measuring device and an electrode that is electrically connectable to the electrocardiogram-measuring device and the non-close-contact surface being provided with the blood-leakage-detecting device and an electrode that is electrically connectable to the blood-leakage-detecting device .
A method of operating a terminal device in a first network that is operating according to a first radio access technology, RAT, the terminal device supporting and operating according to a network interworking feature that enables and controls interworking between the first network and a network operating according to a second RAT, the method comprising: determining whether a first cell in the first network that is serving the terminal device supports the network interworking feature ; and characterized by : modifying the operation of the terminal device with respect to the network interworking feature if it is determined that the first cell does not support the network interworking feature , wherein the step of modifying the operation of the terminal device comprises the terminal device : disabling the network interworking feature or ceasing to act according to the network interworking feature; and refraining from connecting to any WLAN, wherein the first RAT is a 3GPP RAT, the second RAT is a WLAN RAT, and the networking interworking feature is a 3GPP/WLAN interworking feature.
A computer-implemented method of planning a treatment for a patient, the method comprising: receiving, in a processor, a selected treatment protocol for treating the patient, wherein the selected treatment protocol is selected by a user from a list of treatment protocols; presenting, to the user, a display showing the selected treatment protocol as applied to one or more sample patients; receiving proposed modifications to the selected treatment protocol from the user; converting the proposed modifications to the selected treatment protocol into a set of modification instructions in a domain-specific orthodontic treatment language that includes: verb and noun statements of dental treatment phases, conditional statements referencing tooth position, references to one or more tooth by tooth type, and indication of tooth ordering sequences; modifying the selected treatment protocol based on the set of modification instructions in the domain-specific orthodontic treatment language to form a final treatment protocol; and generating a treatment plan using the final treatment protocol. receiving, in a processor, a selected treatment protocol for treating the patient, wherein the selected treatment protocol is selected by a user from a list of treatment protocols; presenting, to the user, a display showing the selected treatment protocol as applied to one or more sample patients; receiving proposed modifications to the selected treatment protocol from the user; converting the proposed modifications to the selected treatment protocol into a set of modification instructions in a domain-specific orthodontic treatment language that includes: verb and noun statements of dental treatment phases, conditional statements referencing tooth position, references to one or more tooth by tooth type, and indication of tooth ordering sequences; modifying the selected treatment protocol based on the set of modification instructions in the domain-specific orthodontic treatment language to form a final treatment protocol; and generating a treatment plan using the final treatment protocol.
A valve mechanism , comprising: a housing including a valve seat that is formed at the outer side, in the radial direction, of an opening at one end of a fluid channel ; a drive valve arranged to be movable in a direction of being contacted to and apart from the valve seat ; a plate-shaped valve body made of an elastic material having an opening through which fluid passes as being arranged between the valve seat and the drive valve ; and a valve positioning member that causes the valve body to face the valve seat via a predetermined gap with respect to the valve seat ; and a drive valve moving mechanism that causes the gap between an inner circumference of the valve body and the valve seat to be variable by moving the drive valve in a direction of approaching the valve seat and elastically deforming the valve body in a direction that the inner circumference of the valve body approaches the valve seat , characterized in that the valve mechanism further comprises a plurality of the valve bodies ; and a spacer sandwiched between the plurality of valve bodies. a housing including a valve seat that is formed at the outer side, in the radial direction, of an opening at one end of a fluid channel ; a drive valve arranged to be movable in a direction of being contacted to and apart from the valve seat ; a plate-shaped valve body made of an elastic material having an opening through which fluid passes as being arranged between the valve seat and the drive valve ; and a valve positioning member that causes the valve body to face the valve seat via a predetermined gap with respect to the valve seat ; and a drive valve moving mechanism that causes the gap between an inner circumference of the valve body and the valve seat to be variable by moving the drive valve in a direction of approaching the valve seat and elastically deforming the valve body in a direction that the inner circumference of the valve body approaches the valve seat , characterized in that the valve mechanism further comprises a plurality of the valve bodies ; and a spacer sandwiched between the plurality of valve bodies.
An automated method of treating a tissue or cytology sample mounted on a glass slide to alleviate staining obfuscations associated with pigments within the tissue or cytology sample, the method comprising the steps of: • placing the glass slide upon which the tissue or cytology sample is mounted on an automated instrument, • applying a clarifying reagent including about 1% to about 12% hydrogen peroxide (v/v) so that the clarifying reagent contacts the tissue or cytology sample and the pigments within the tissue or cytology sample are decolorized, • applying heat to the glass slide so that the tissue or cytology sample and the clarifying reagent are maintained at a predetermined temperature while in contact, wherein the predetermined temperature is between about 35 °C and about 100 °C, • applying a rinsing reagent so that the clarifying reagent is substantially removed from contacting the tissue or cytology sample, and • applying a chromogenic reagent so that the tissue or cytology sample is specifically stained; wherein the pigments within the tissue or cytology sample are decolorized so that the specifically stained tissue or cytology sample exhibits morphological characteristics consistent with those of the tissue or cytology sample prior to the applying the clarifying reagent or exhibits antigenic and genetic characteristics consistent with or improved with respect to those of the tissue or cytology sample prior to applying the clarifying reagent. • placing the glass slide upon which the tissue or cytology sample is mounted on an automated instrument, • applying a clarifying reagent including about 1% to about 12% hydrogen peroxide (v/v) so that the clarifying reagent contacts the tissue or cytology sample and the pigments within the tissue or cytology sample are decolorized, • applying heat to the glass slide so that the tissue or cytology sample and the clarifying reagent are maintained at a predetermined temperature while in contact, wherein the predetermined temperature is between about 35 °C and about 100 °C, • applying a rinsing reagent so that the clarifying reagent is substantially removed from contacting the tissue or cytology sample, and • applying a chromogenic reagent so that the tissue or cytology sample is specifically stained;
A method for depolymerization of polyester, said method comprising: (a) treating said polyester with methanol in a depolymerization reaction system comprising at least one depolymerization reactor under conditions sufficient to depolymerize at least some of said polyester and form a depolymerization reaction product comprising dimethyl terephthalate and at least one diol; and (b) converting in said depolymerization reaction system at least some of said diol of said depolymerization reaction product to a compound substantially non-reactive with said dimethyl terephthalate and said polyester, optionally wherein treating step (a) and converting step (b) form in said depolymerization reaction system a reaction product mixture that includes dimethyl terephthalate; at least one diol; and a compound substantially non-reactive with the dimethyl terephthalate and the polyester. (a) treating said polyester with methanol in a depolymerization reaction system comprising at least one depolymerization reactor under conditions sufficient to depolymerize at least some of said polyester and form a depolymerization reaction product comprising dimethyl terephthalate and at least one diol; and (b) converting in said depolymerization reaction system at least some of said diol of said depolymerization reaction product to a compound substantially non-reactive with said dimethyl terephthalate and said polyester,
A label issuing apparatus , comprising: a printer interface; and a processor configured to: generate print data for an image including a first region with first information and a second region with a first code symbol representing the first information and a second code symbol representing the first information but of a size different than a size of the first code symbol, and control the printer interface to transmit the print data; wherein: the second code symbol is larger than the first code symbol; the first and second code symbols are adjacent to each other in the horizontal direction in the second region , the first region is adjacent to the second region in the vertical direction; and the image further includes a third region adjacent to the second region in the vertical direction and including a third code symbol identical to the first code symbol and a fourth code symbol identical to the second code symbol. a printer interface; and a processor configured to: generate print data for an image including a first region with first information and a second region with a first code symbol representing the first information and a second code symbol representing the first information but of a size different than a size of the first code symbol, and control the printer interface to transmit the print data; wherein: the second code symbol is larger than the first code symbol; the first and second code symbols are adjacent to each other in the horizontal direction in the second region , the first region is adjacent to the second region in the vertical direction; and the image further includes a third region adjacent to the second region in the vertical direction and including a third code symbol identical to the first code symbol and a fourth code symbol identical to the second code symbol. generate print data for an image including a first region with first information and a second region with a first code symbol representing the first information and a second code symbol representing the first information but of a size different than a size of the first code symbol, and control the printer interface to transmit the print data; wherein: the second code symbol is larger than the first code symbol; the first and second code symbols are adjacent to each other in the horizontal direction in the second region , the first region is adjacent to the second region in the vertical direction; and the image further includes a third region adjacent to the second region in the vertical direction and including a third code symbol identical to the first code symbol and a fourth code symbol identical to the second code symbol. the second code symbol is larger than the first code symbol; the first and second code symbols are adjacent to each other in the horizontal direction in the second region , the first region is adjacent to the second region in the vertical direction; and the image further includes a third region adjacent to the second region in the vertical direction and including a third code symbol identical to the first code symbol and a fourth code symbol identical to the second code symbol.
A fronthaul control device comprising: a bandwidth identification unit configured to identify a frequency bandwidth (BW2, BW2') of a particular cell (C2) among a plurality of cells (C1, C2, ... , Cn) received from and calculated by a self-organizing network according to an optical wavelength data rate required for the particular cell (C2) included in off-level information which is received from a digital unit pool and relates to information minimally required for calculating a frequency bandwidth in an off-state of the particular cell (C2), wherein the bandwidth identification unit is further configured to identify that a frequency bandwidth of the particular cell (C2) in the off-state becomes narrower than a frequency bandwidth of the particular cell (C2) in a previous on-state; a center wavelength determination unit configured to determine a center wavelength (CP2) for allocating the frequency bandwidth (BW2, BW2') of the particular cell (C2); and an optical wavelength band allocation unit configured to allocate an optical wavelength band to the particular cell (C2) on the basis of the center wavelength (CP2) and the frequency bandwidth (BW2, BW2') of the particular cell (C2), wherein the center wavelength (CP2) is determined such that the optical wavelength band allocated to the particular cell (C2) is adjacent to an optical wavelength band allocated to at least one of other cells other than the particular cell (C2) among the plurality of cells (C1, C2, ... , Cn). a bandwidth identification unit configured to identify a frequency bandwidth (BW2, BW2') of a particular cell (C2) among a plurality of cells (C1, C2, ... , Cn) received from and calculated by a self-organizing network according to an optical wavelength data rate required for the particular cell (C2) included in off-level information which is received from a digital unit pool and relates to information minimally required for calculating a frequency bandwidth in an off-state of the particular cell (C2), wherein the bandwidth identification unit is further configured to identify that a frequency bandwidth of the particular cell (C2) in the off-state becomes narrower than a frequency bandwidth of the particular cell (C2) in a previous on-state; a center wavelength determination unit configured to determine a center wavelength (CP2) for allocating the frequency bandwidth (BW2, BW2') of the particular cell (C2); and an optical wavelength band allocation unit configured to allocate an optical wavelength band to the particular cell (C2) on the basis of the center wavelength (CP2) and the frequency bandwidth (BW2, BW2') of the particular cell (C2), wherein the center wavelength (CP2) is determined such that the optical wavelength band allocated to the particular cell (C2) is adjacent to an optical wavelength band allocated to at least one of other cells other than the particular cell (C2) among the plurality of cells (C1, C2, ... , Cn).
A capture agent that specifically binds botulinum neurotoxin serotype A protein, wherein the capture agent comprises an anchor ligand, a linker, and a secondary ligand, wherein the anchor ligand comprises a cyclic peptide comprising the formula of Dab(DNP)-R-Lys(N3)-T-Dab-Pra-L-NH-, wherein the secondary ligand binds to residues 166-179 of the botulinum neurotoxin serotype A protein light chain, wherein the anchor ligand and the secondary ligand specifically bind the botulinum neurotoxin serotype A protein at distinct epitopes, and wherein the linker has a length that is within 10% of the distance between the anchor ligand and the secondary ligand when both ligands are bound to the botulinum neurotoxin serotype A protein.
A medical image processing apparatus comprising: an image acquiring unit configured to acquire a plurality of medical images obtained by imaging an identical region of an object under different radiographing conditions; a relation acquiring unit configured to acquire a correlation between a signal value and a radiographing condition at a pixel at a same coordinate position in the plurality of medical images; a condition acquiring unit configured to acquire a virtual radiographing condition that is different from the radiographing conditions of the plurality of medical images; a generating unit configured to generate a diagnosis image by acquiring a signal value of each pixel of the diagnosis image, at the same coordinate position, based on the correlation and the virtual radiographing condition; a display condition acquiring unit configured to acquire a window width value and a window level value for displaying one medical image of an identical cross section of the object; and a display control unit configured to cause a display unit to display the diagnosis image based on the window width value and window level value acquired by the display condition acquiring unit, wherein the image acquiring unit is configured to acquire the said plurality of medical images as CT images at the identical region of the object under different radiographing conditions; and the radiographing conditions are X-ray tube voltages. an image acquiring unit configured to acquire a plurality of medical images obtained by imaging an identical region of an object under different radiographing conditions; a relation acquiring unit configured to acquire a correlation between a signal value and a radiographing condition at a pixel at a same coordinate position in the plurality of medical images; a condition acquiring unit configured to acquire a virtual radiographing condition that is different from the radiographing conditions of the plurality of medical images; a generating unit configured to generate a diagnosis image by acquiring a signal value of each pixel of the diagnosis image, at the same coordinate position, based on the correlation and the virtual radiographing condition; a display condition acquiring unit configured to acquire a window width value and a window level value for displaying one medical image of an identical cross section of the object; and a display control unit configured to cause a display unit to display the diagnosis image based on the window width value and window level value acquired by the display condition acquiring unit, wherein the image acquiring unit is configured to acquire the said plurality of medical images as CT images at the identical region of the object under different radiographing conditions; and the radiographing conditions are X-ray tube voltages.
A hand-held percussive shaker instrument (20; 30) comprising: a body which comprises: a first enclosure (21; 31), the first enclosure comprising a first sound producing material; a second enclosure (22; 32), the second enclosure comprising a second sound producing material; and a center assembly (23; 33), the center assembly fixedly connected to the first enclosure and the second enclosure; and a lock assembly , the lock assembly integrally formed in the center assembly (23; 33) of the body, characterized in that the lock assembly is arranged to connect detachably the hand-held percussive shaker instrument (20; 30) to another identical hand-held percussive shaker instrument, and in that the center assembly is cylindrical and has a first semi-cylindrical member and a second semi-cylindrical member , the first semi-cylindrical member held to the second semi-cylindrical member. a body which comprises: a first enclosure (21; 31), the first enclosure comprising a first sound producing material; a second enclosure (22; 32), the second enclosure comprising a second sound producing material; and a center assembly (23; 33), the center assembly fixedly connected to the first enclosure and the second enclosure; and a first enclosure (21; 31), the first enclosure comprising a first sound producing material; a second enclosure (22; 32), the second enclosure comprising a second sound producing material; and a center assembly (23; 33), the center assembly fixedly connected to the first enclosure and the second enclosure; and a lock assembly , the lock assembly integrally formed in the center assembly (23; 33) of the body,
A calcium hypochlorite shaped article suitable for disinfecting water, the shaped article comprising a blend of calcium hypochlorite and calcium hydroxide, wherein the total calcium hydroxide content in the shaped article is greater than 10% by weight, based on the total weight of the shaped article.